Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2022-05-16
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$617.2m
reported value
-15.6% vs Q4 2021
27positions
74.3%in top 10
6 new
3 added
2 reduced
5 sold out
vs Q4 2021
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ACLARIS THERAPEUTICS INC ACRS | $78.7m12.75% | Unchanged |
| INSTIL BIO INC COM | $73.8m11.96% | Unchanged |
| RELMADA THERAPEUTICS INC RLMD | $61.3m9.93% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $51.4m8.33% | Unchanged |
| GH RESEARCH PLC GHRS | $37.5m6.08% | Added +29.1k |
| TRICIDA INC TCDA | $36.9m5.99% | Added +1.0m |
| VIRIDIAN THERAPEUTICS INC VRDN | $34.3m5.55% | Unchanged |
| MARINUS PHARMACEUTICALS INC MRNS | $29.5m4.78% | Added +276.7k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $29.5m4.77% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $26.0m4.20% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $21.0m3.40% | Unchanged |
| LIANBIO LIANY | $20.0m3.23% | Unchanged |
| VISTAGEN THERAPEUTICS INC VTGN | $19.9m3.22% | Unchanged |
| ATHIRA PHARMA INC COM | $13.5m2.19% | Unchanged |
| EIGER BIOPHARMACEUTICALS INC CLDN | $12.2m1.98% | New |
| NUVALENT INC COM | $11.2m1.81% | Unchanged |
| GRAPHITE BIO INC GRPH | $8.2m1.33% | Unchanged |
| PROVENTION BIO INC PRVB | $8.2m1.33% | New |
| COGENT BIOSCIENCES INC COGT | $8.2m1.32% | Unchanged |
| ATYR PHARMA INC ATYR | $7.5m1.21% | Reduced -166.1k |
| AFFIMED N V COM | $6.2m1.01% | Unchanged |
| SIERRA ONCOLOGY INC COM NEW | $5.2m0.84% | New |
| ALTIMMUNE INC ALT | $4.6m0.75% | New |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $3.7m0.60% | Reduced -715.9k |
| ASTRIA THERAPEUTICS INC CATB | $3.6m0.59% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $2.8m0.45% | New |
| SAVARA INC SVRA | $2.5m0.40% | New |
Sold out since Q4 2021
| Security | Value then |
|---|---|
| KINNATE BIOPHARMA INC KNTE | $13.7m773.0k shares |
| OLEMA PHARMACEUTICALS INC OLMA | $7.6m816.7k shares |
| CVRX INC CVRX | $6.5m533.4k shares |
| AKOYA BIOSCIENCES INC AKYA | $6.1m400.0k shares |
| CORVUS PHARMACEUTICALS INC CRVS | $603.0k250.0k shares |